Suppression of neuropeptide F extends longevity in flies
The relationship between insulin and ageing in flies could have far-reaching implications for diabetes and obesity drugs for humans.
List view / Grid view
The relationship between insulin and ageing in flies could have far-reaching implications for diabetes and obesity drugs for humans.
Researchers suggest that integrating genetically diverse mouse models with cell-based assays will better replicate human diseases.
In this Q&A, Dr Ronald DePinho of MD Anderson elucidates their preclinical proof-of-concept that adjusting TERT levels could be a viable therapeutic approach for mitigating age-related diseases, such as cancer, heart disease and Alzheimer’s.
Biomarkers found through urinary and exosome proteome profiling have potential for diagnosis and disease monitoring.
Researchers found heightened SCAN enzyme activity in humans and mice with diabetes results in excessive nitric oxide on insulin receptors.
How stem cells become enteroendocrine cells using gut organoids could have positive implications for many gastrointestinal diseases.
New Study from King's College London: Irregular Sleep Patterns Tied to Harmful Gut Bacteria.
The University of California underwent a mouse study disclosing underlying sex differences in mice for obesity.
Spanish researchers looking at two crucial proteins uncover how cells release mucin and insulin, leading to new methods to reset deregulation.
Japanese researchers discover the mechanism of inhibition of diet-induced obesity in mice by the glucose-dependent insulinotropic polypeptide
US researchers have invented a drug delivery technology that has implications for opioid epidemic, cancer treatment, rehabilitation care and more.
The NPGPx protein is active in foetuses, but largely dormant and absent in diabetic adults.
Trinity College Dublin has developed a new technique that accurately determines the state of macrophages.
Drug-initiated activity metabolomics screening discovers the metabolite myristoylglycine, that converts white fat cells to brown fat cells.
Researchers have discovered a protein, Ait1, that is responsible for controlling cell growth in yeasts. Since humans and yeasts have remarkably similar cellular mechanisms, teasing out the differences presents drug developers with new target.